CViSB Center renewed with $12.8 million grant
Scientists at Scripps Research have received a significant grant to study the evolution and outcomes of human infections with SARS-CoV-2, Lassa virus and Ebola virus. The team will receive roughly $2.5 million each year for a maximum of five years, bringing the total potential award to $12.8 million. The funds—a grant renewal from the the National Institutes of Health’s (NIH)…
Kristian AndersenApril 13, 2023